| Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer KC Arbour, L Mezquita, N Long, H Rizvi, E Auclin, A Ni, G Martínez-Bernal, ... Journal of Clinical Oncology 36 (28), 2872-2878, 2018 | 887 | 2018 |
| Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … JW Goldman, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet Oncology 22 (1), 51-65, 2021 | 446 | 2021 |
| Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ AMC Dingemans, M Früh, A Ardizzoni, B Besse, C Faivre-Finn, ... Annals of Oncology 32 (7), 839-853, 2021 | 303 | 2021 |
| Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ LE Hendriks, KM Kerr, J Menis, TS Mok, U Nestle, A Passaro, S Peters, ... Annals of Oncology 34 (4), 339-357, 2023 | 235 | 2023 |
| Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ... Journal of thoracic oncology 14 (12), 2109-2119, 2019 | 235 | 2019 |
| Outcome of patients with non–small cell lung cancer and brain metastases treated with checkpoint inhibitors LEL Hendriks, C Henon, E Auclin, L Mezquita, R Ferrara, ... Journal of Thoracic Oncology 14 (7), 1244-1254, 2019 | 222 | 2019 |
| Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ LE Hendriks, KM Kerr, J Menis, TS Mok, U Nestle, A Passaro, S Peters, ... Annals of Oncology 34 (4), 358-376, 2023 | 159 | 2023 |
| EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? LEL Hendriks, EF Smit, BAH Vosse, WW Mellema, DAM Heideman, ... Lung cancer 84 (1), 86-91, 2014 | 132 | 2014 |
| Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: a retrospective cohort analysis JL Kuiper, LE Hendriks, AJ van der Wekken, AJ de Langen, I Bahce, ... Lung cancer 89 (3), 255-261, 2015 | 131 | 2015 |
| EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins J Remon, LEL Hendriks, AF Cardona, B Besse Cancer treatment reviews 90, 102105, 2020 | 128 | 2020 |
| Clinical features of large cell neuroendocrine carcinoma: a population-based overview JL Derks, LE Hendriks, WA Buikhuisen, HJM Groen, E Thunnissen, ... European Respiratory Journal 47 (2), 615-624, 2016 | 120 | 2016 |
| Prevention and early detection for NSCLC: advances in thoracic oncology 2018 H Balata, KM Fong, LE Hendriks, S Lam, JS Ostroff, N Peled, N Wu, ... Journal of Thoracic Oncology 14 (9), 1513-1527, 2019 | 105 | 2019 |
| Circulating T-cell immunosenescence in patients with advanced non–small cell lung cancer treated with single-agent PD-1/PD-L1 inhibitors or platinum-based chemotherapy R Ferrara, M Naigeon, E Auclin, B Duchemann, L Cassard, JM Jouniaux, ... Clinical Cancer Research 27 (2), 492-503, 2021 | 95 | 2021 |
| Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy LE Hendriks, E Rouleau, B Besse Translational lung cancer research 7 (6), 647, 2018 | 90 | 2018 |
| Progression-free survival and overall survival beyond 5 years of NSCLC patients with synchronous oligometastases treated in a prospective phase II trial (NCT 01282450) D De Ruysscher, R Wanders, LE Hendriks, A van Baardwijk, B Reymen, ... Journal of Thoracic Oncology 13 (12), 1958-1961, 2018 | 88 | 2018 |
| Dichotomous ALK-IHC is a better predictor for ALK inhibition outcome than traditional ALK-FISH in advanced non–small cell lung cancer AJ Van der Wekken, R Pelgrim, N 't Hart, N Werner, MF Mastik, L Hendriks, ... Clinical cancer research 23 (15), 4251-4258, 2017 | 84 | 2017 |
| Management of stage I and II nonsmall cell lung cancer F McDonald, M De Waele, LEL Hendriks, C Faivre-Finn, AMC Dingemans, ... European Respiratory Journal 49 (1), 2017 | 84 | 2017 |
| Dutch Oncology COVID-19 consortium: outcome of COVID-19 in patients with cancer in a nationwide cohort study K de Joode, DW Dumoulin, J Tol, HM Westgeest, LV Beerepoot, ... European Journal of Cancer 141, 171-184, 2020 | 82 | 2020 |
| Automated detection and segmentation of non-small cell lung cancer computed tomography images SP Primakov, A Ibrahim, JE van Timmeren, G Wu, SA Keek, M Beuque, ... Nature communications 13 (1), 3423, 2022 | 76 | 2022 |
| Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression M Aldea, L Hendriks, L Mezquita, C Jovelet, D Planchard, E Auclin, ... Journal of Thoracic Oncology 15 (3), 383-391, 2020 | 67 | 2020 |
